Literature DB >> 34316576

Antibiotic Prescribing Patterns at COVID-19 Dedicated Wards in Bangladesh: Findings from a Single Center Study.

Md Maruf Ahmed Molla1, Mahmuda Yeasmin1, Md Khairul Islam2, Md Mohiuddin Sharif2, Md Robed Amin2, Tasnim Nafisa1, Asish Kumar Ghosh2, Monira Parveen3, Md Masum Hossain Arif4, Junaid Abdullah Jamiul Alam2, Syed Jafar Raza Rizvi5, K M Saif-Ur-Rahman6, Arifa Akram1, A K M Shamsuzzaman1.   

Abstract

BACKGROUND: As evidence is mounting regarding irrational and often unnecessary use of antibiotics during the COVID-19 pandemic a cross-sectional Point Prevalence Survey (PPS) (in accordance with WHO guideline) was conducted across COVID-19 dedicated wards in Dhaka Medical College and Hospital (DMCH).
METHODOLOGY: Antibiotic usage data were collected from 193 patients at different COVID-19 dedicated wards at DMCH on 11 June 2020. Comparisons in antibiotic usage were made between different groups using Pearson chi-square and Fisher's exact test. RESULT: Findings reveal all surveyed patients (100%) were receiving at least one antibiotic with 133 patients (68.91%) receiving multiple antibiotics. Overall, patients presenting with the severe disease received more antibiotics. Third-generation cephalosporins (i.e. ceftriaxone) (53.8%), meropenem (40.9%), moxifloxacin (29.5%), and doxycycline (25.4%) were the four most prescribed antibiotics among surveyed patients. Diabetes mellitus (DM) was independently associated with multiple antibiotic prescribing. Abnormal C-reactive protein (CRP) and serum d-dimer were linked with higher odds of multiple antibiotic prescribing among study patients.
CONCLUSION: Prevalence of multiple antibiotic prescriptions was high among severely ill patients and those with abnormal CRP and d-dimer levels. Data regarding the quality of antibiotic prescribing were lacking.
© 2021 The Authors.

Entities:  

Keywords:  Antimicrobial resistance; Bangladesh; COVID-19; Point prevalence survey; SARS-CoV-2

Year:  2021        PMID: 34316576      PMCID: PMC7910658          DOI: 10.1016/j.infpip.2021.100134

Source DB:  PubMed          Journal:  Infect Prev Pract        ISSN: 2590-0889


  10 in total

Review 1.  Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.

Authors:  Timothy M Rawson; Luke S P Moore; Nina Zhu; Nishanthy Ranganathan; Keira Skolimowska; Mark Gilchrist; Giovanni Satta; Graham Cooke; Alison Holmes
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

Review 2.  Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme.

Authors:  Dilip Nathwani; Jacqueline Sneddon; William Malcolm; Camilla Wiuff; Andrea Patton; Simon Hurding; Anne Eastaway; R Andrew Seaton; Emma Watson; Elizabeth Gillies; Peter Davey; Marion Bennie
Journal:  Int J Antimicrob Agents       Date:  2011-04-22       Impact factor: 5.283

3.  Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

4.  COVID-19: don't neglect antimicrobial stewardship principles!

Authors:  B D Huttner; G Catho; J R Pano-Pardo; C Pulcini; J Schouten
Journal:  Clin Microbiol Infect       Date:  2020-04-30       Impact factor: 8.067

Review 5.  Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Fareeha Fiayyaz; Shakila Sabir; Mohsin Khurshid
Journal:  Arch Microbiol       Date:  2020-02-03       Impact factor: 2.667

6.  Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study.

Authors:  Jian Wu; Jun Liu; Xinguo Zhao; Chengyuan Liu; Wei Wang; Dawei Wang; Wei Xu; Chunyu Zhang; Jiong Yu; Bin Jiang; Hongcui Cao; Lanjuan Li
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

7.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

8.  Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19.

Authors:  Waqas Ullah; Nishanth Thalambedu; Shujaul Haq; Rehan Saeed; Shristi Khanal; Shafaq Tariq; Sohaib Roomi; John Madara; Margot Boigon; Donald C Haas; David L Fischman
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-09-03

9.  A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).

Authors:  Sock Hoon Tan; Tat Ming Ng; Hui Lin Tay; Min Yi Yap; Shi Thong Heng; Audrey Yong Xin Loo; Christine B Teng; Tau Hong Lee
Journal:  J Glob Antimicrob Resist       Date:  2020-12-08       Impact factor: 4.035

10.  Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.

Authors:  Ronald A Seaton; Cheryl L Gibbons; Lesley Cooper; William Malcolm; Rachel McKinney; Stephanie Dundas; David Griffith; Danielle Jeffreys; Kayleigh Hamilton; Brian Choo-Kang; Suzanne Brittain; Debbie Guthrie; Jacqueline Sneddon
Journal:  J Infect       Date:  2020-09-26       Impact factor: 6.072

  10 in total
  9 in total

1.  Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications.

Authors:  Kiran Ramzan; Sameen Shafiq; Iqra Raees; Zia Ul Mustafa; Muhammad Salman; Amer Hayat Khan; Johanna C Meyer; Brian Godman
Journal:  Antibiotics (Basel)       Date:  2022-06-09

2.  Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.

Authors:  Zia Ul Mustafa; Muhammad Salman Saleem; Muhammad Nabeel Ikram; Muhammad Salman; Sanan Amjad Butt; Shehroze Khan; Brian Godman; R Andrew Seaton
Journal:  Pathog Glob Health       Date:  2021-11-16       Impact factor: 3.735

3.  Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.

Authors:  Ashrafur Rahaman Mahadi
Journal:  Front Public Health       Date:  2021-12-17

4.  The landscape of antibiotic usage among COVID-19 patients in the early phase of pandemic: a Malaysian national perspective.

Authors:  Izzati-Nadhirah Mohamad; Calvin Ke-Wen Wong; Chii-Chii Chew; E-Li Leong; Biing-Horng Lee; Cheng-Keat Moh; Komalah Chenasammy; Steven Chee-Loon Lim; Hong-Bee Ker
Journal:  J Pharm Policy Pract       Date:  2022-01-11

5.  Antibiotic Use in Suspected and Confirmed COVID-19 Patients Admitted to Health Facilities in Sierra Leone in 2020-2021: Practice Does Not Follow Policy.

Authors:  Ibrahim Franklyn Kamara; Ajay M V Kumar; Anna Maruta; Bobson Derrick Fofanah; Charles Kuria Njuguna; Steven Shongwe; Francis Moses; Sia Morenike Tengbe; Joseph Sam Kanu; Sulaiman Lakoh; Alie H D Mansaray; Kalaiselvi Selvaraj; Mohammed Khogali; Rony Zachariah
Journal:  Int J Environ Res Public Health       Date:  2022-03-28       Impact factor: 3.390

6.  Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.

Authors:  Faisal Salman Alshaikh; Brian Godman; Oula Nawaf Sindi; R Andrew Seaton; Amanj Kurdi
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

7.  Comparison of antibiotic use in the COVID-19 pandemic with the pre-pandemic period in a university hospital.

Authors:  Ilknur Erdem; Enes Ardic; Ece Turker; Muhammed Enes Kardan; Mahluga Javarova Demirkapu
Journal:  Arch Med Sci       Date:  2022-08-30       Impact factor: 3.707

8.  Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study.

Authors:  Kona Chowdhury; Mainul Haque; Nadia Nusrat; Nihad Adnan; Salequl Islam; Afzalunnessa Binte Lutfor; Dilara Begum; Arif Rabbany; Enamul Karim; Abdul Malek; Nasim Jahan; Jesmine Akter; Sumala Ashraf; Mohammad Nazmul Hasan; Mahmuda Hassan; Najnin Akhter; Monika Mazumder; Nazmus Sihan; Nurun Naher; Shaheen Akter; Sifat Uz Zaman; Tanjina Chowdhury; Jebun Nesa; Susmita Biswas; Mohammod Didarul Islam; Al Mamun Hossain; Habibur Rahman; Palash Kumar Biswas; Mohammed Shaheen; Farah Chowdhury; Santosh Kumar; Amanj Kurdi; Zia Ul Mustafa; Natalie Schellack; Marshall Gowere; Johanna C Meyer; Sylvia Opanga; Brian Godman
Journal:  Antibiotics (Basel)       Date:  2022-01-14

9.  Genetic Diversity, Antimicrobial Resistance Pattern, and Biofilm Formation in Klebsiella pneumoniae Isolated from Patients with Coronavirus Disease 2019 (COVID-19) and Ventilator-Associated Pneumonia.

Authors:  Asma Ghanizadeh; Maede Najafizade; Somaye Rashki; Zeynab Marzhoseyni; Mitra Motallebi
Journal:  Biomed Res Int       Date:  2021-12-24       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.